Bio-Path Holdings Files S-1
Ticker: BPTH · Form: S-1 · Filed: Jan 21, 2025 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | S-1 |
| Filed Date | Jan 21, 2025 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001, $0.125 |
| Sentiment | neutral |
Sentiment: neutral
Topics: S-1, pharmaceutical, filing
TL;DR
Bio-Path Holdings filed an S-1, check financials and future plans.
AI Summary
Bio-Path Holdings, Inc. filed an S-1 form on January 21, 2025, detailing its business and financial information. The company, previously known as Ogden Golf Co Corp, is incorporated in Delaware and operates in the pharmaceutical preparations sector. Its principal executive offices are located at 4710 Bellaire Boulevard, Suite 210, Bellaire, TX 77401.
Why It Matters
This S-1 filing provides crucial information for investors and the public regarding Bio-Path Holdings' financial health and strategic direction.
Risk Assessment
Risk Level: medium — S-1 filings often indicate a company is seeking to raise capital or undergo significant corporate changes, which inherently carry risks.
Key Numbers
- 33.63 — Stock Price (Appears in filing data, likely related to a specific period.)
- 38.12 — Stock Price (Appears in filing data, likely related to a specific period.)
- 617633 — Number of Shares (Appears in filing data, context unclear without full document.)
- 3710000 — Monetary Amount (Appears in filing data, context unclear without full document.)
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Filer
- 0001104659-25-004576 (filing_id) — Accession Number
- 20250121 (date) — Filing Date
- 0001133818 (cik) — Central Index Key
- 2834 (sic_code) — Standard Industrial Classification
- 4710 BELLAIRE BOULEVARD, SUITE 210, BELLAIRE, TX 77401 (address) — Business Address
- OGDEN GOLF CO CORP (company) — Former Company Name
- 20080221 (date) — Former Company Name Change Date
- 20010205 (date) — Former Company Name Change Date
- bpth-20240930xs1.htm (document_name) — Form S-1 Document Name
FAQ
What is the primary purpose of this S-1 filing for Bio-Path Holdings, Inc.?
The S-1 filing is typically used by companies to register securities for public sale, indicating potential offerings or significant corporate actions.
When was Bio-Path Holdings, Inc. previously known by another name?
The company was formerly known as Ogden Golf Co Corp, with a name change date of February 21, 2008.
What industry does Bio-Path Holdings, Inc. operate in?
Bio-Path Holdings, Inc. operates in the Pharmaceutical Preparations sector, with a Standard Industrial Classification code of 2834.
What are the business and mailing addresses for Bio-Path Holdings, Inc.?
The business and mailing addresses are both listed as 4710 Bellaire Boulevard, Suite 210, Bellaire, TX 77401.
What specific drug candidate is mentioned in the filing data?
The drug candidate 'Prexigebersen' is mentioned in the filing data, associated with dates in 2022 and 2023.
Filing Stats: 4,616 words · 18 min read · ~15 pages · Grade level 16.2 · Accepted 2025-01-21 06:10:00
Key Financial Figures
- $0.001 — o shares of our common stock, par value $0.001 per share, together with (i) Series A w
- $0.125 — hare under Nasdaq Rule 5635(d) plus (b) $0.125 per whole share of common stock underly
Filing Documents
- bpth-20240930xs1.htm (S-1) — 2923KB
- bpth-20240930xex23d1.htm (EX-23.1) — 5KB
- bpth-20240930xexfees.htm (EX-FILING FEES) — 81KB
- bpth-20240930xs1002.jpg (GRAPHIC) — 11KB
- bpth-20240930xs1006.jpg (GRAPHIC) — 26KB
- bpth-20240930xs1007.jpg (GRAPHIC) — 34KB
- bpth-20240930xs1008.jpg (GRAPHIC) — 31KB
- bpth-20240930xs1010.jpg (GRAPHIC) — 35KB
- bpth-20240930xs1011.jpg (GRAPHIC) — 18KB
- bpth-20240930xs1012.jpg (GRAPHIC) — 18KB
- bpth-20240930xs1021.jpg (GRAPHIC) — 11KB
- 0001104659-25-004576.txt ( ) — 10839KB
- bpth-20240930.xsd (EX-101.SCH) — 64KB
- bpth-20240930_cal.xml (EX-101.CAL) — 44KB
- bpth-20240930_def.xml (EX-101.DEF) — 276KB
- bpth-20240930_lab.xml (EX-101.LAB) — 432KB
- bpth-20240930_pre.xml (EX-101.PRE) — 515KB
- bpth-20240930xs1_htm.xml (XML) — 1354KB
RISK FACTORS
RISK FACTORS 11 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS 39
USE OF PROCEEDS
USE OF PROCEEDS 41
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 44
BUSINESS
BUSINESS 56 DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 76
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 82 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS, AND DIRECTOR INDEPENDENCE 91
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 92
DESCRIPTION OF CAPITAL STOCK
DESCRIPTION OF CAPITAL STOCK 93
DESCRIPTION OF SECURITIES WE ARE OFFERING
DESCRIPTION OF SECURITIES WE ARE OFFERING 95 PLAN OF DISTRIBUTION 99 LEGAL MATTERS 102 EXPERTS 102 WHERE YOU CAN FIND MORE INFORMATION 102 i Table of Contents ABOUT THIS PROSPECTUS The registration statement we filed with the Securities and Exchange Commission (the "SEC") includes exhibits that provide more detail of the matters discussed in this prospectus. You should read this prospectus and the related exhibits filed with the SEC before making your investment decision. You should rely only on the information provided in this prospectus. In addition, this prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. This prospectus includes important information about us, the securities being offered and other information you should know before investing in our securities. You should not assume that the information contained in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus, even though this prospectus is delivered or securities are sold or otherwise disposed of on a later date. It is important for you to read and consider all information contained in this prospectus in making your investment decision. All of the summaries in this prospectus are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading "Where You Can Find More Information." We have not, and the Placement Agent has not, authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we have referre